These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7288553)

  • 1. Acute toxicity and pharmacokinetics of dibekacin mice.
    Komiya I; Murata S; Umemura K; Tomono N; Kikai S; Fujita M
    J Pharmacobiodyn; 1981 May; 4(5):356-61. PubMed ID: 7288553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of dibekacin in rabbits and dogs.
    Komiya I; Murata S; Umemura K; Tomono N; Kikai S; Fujita M
    J Pharmacobiodyn; 1981 May; 4(5):362-73. PubMed ID: 7288554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of infusion time on the pharmacokinetics of dibekacin in rabbits.
    Navarro AS; Lanao JM; Dominguez-Gil A
    J Antibiot (Tokyo); 1984 Mar; 37(3):285-92. PubMed ID: 6725142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic studies with dibekacin, a new aminoglycoside, after intravenous and intramuscular administration to human volunteers.
    Goto M; Sugiyama M; Ishizaki T
    Antimicrob Agents Chemother; 1980 Sep; 18(3):372-6. PubMed ID: 6775594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on administration method of dibekacin].
    Soejima R; Tano Y; Niki Y; Katoh O
    Jpn J Antibiot; 1982 Dec; 35(12):2768-72. PubMed ID: 7182532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Absorption, distribution, and excretion of arbekacin after intravenous and intramuscular administration in rats].
    Mitomi N; Matsumoto T; Fujigaki M; Komiya I; Kai F
    Jpn J Antibiot; 1987 Feb; 40(2):357-64. PubMed ID: 3599384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of dibekacin after intramuscular administration in man.
    Umemura K; Komiya I; Nakadori S; Chow SY
    Jpn J Antibiot; 1977 Sep; 30(9):650-6. PubMed ID: 916185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of arbekacin in dogs. I. Serum concentration and urinary excretion].
    Tomono N; Sannomiya F; Nakayoshi T; Shinkai S; Fujita M
    Jpn J Antibiot; 1987 Feb; 40(2):365-75. PubMed ID: 3599385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical studies on dibekacin for infectious diseases following intramuscular and intravenous drip administration. Concentration in infected tissues and clinical responses (author's transl)].
    Nakamura T; Hashimoto I; Sawada Y; Mikami J; Bekki E; Kasai Y; Nakanishi M
    Jpn J Antibiot; 1981 Jun; 34(6):980-93. PubMed ID: 7289045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mode of administration on distribution of dibekacin in rabbits.
    Navarro AS; Lanao JM; Dominguez-Gil A
    J Antimicrob Chemother; 1987 Jun; 19(6):799-806. PubMed ID: 3610907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic studies on intravenous drip infusion of dibekacin in elderly subjects without apparent renal failure (author's transl)].
    Sawae Y; Okada K; Umemura K
    Jpn J Antibiot; 1982 Mar; 35(3):770-8. PubMed ID: 7097979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics and pharmacokinetics of dibekacin in the neonate--comparison between the intramuscular and intravenous routes.
    Autret E; Borderon JC; Saliba E; Koki P; Ployet MJ; Gold F; Breteau M; Laugier J
    Dev Pharmacol Ther; 1984; 7 Suppl 1():121-4. PubMed ID: 6518951
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood levels of dibekacin following intravenous drip infusion (author's transl)].
    Sawae Y; Hatta Y; Takii M
    Jpn J Antibiot; 1977 Sep; 30(9):667-71. PubMed ID: 916186
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fundamental and clinical studies on intravenous drip infusion of dibekacin in the pediatric field].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Sakaguchi Y; Kimura K
    Jpn J Antibiot; 1985 Aug; 38(8):2068-86. PubMed ID: 4079001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of dibekacin in normal subjects and in patients with renal failure.
    Leroy A; Humbert G; Fillastre JP
    J Antimicrob Chemother; 1980 Jan; 6(1):113-20. PubMed ID: 7358604
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacokinetics of arbekacin in dogs. II. The distribution of arbekacin in tissues].
    Tomono N; Nakayoshi T; Shinkai S; Fujita M
    Jpn J Antibiot; 1987 Feb; 40(2):377-84. PubMed ID: 3599386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of circadian changes of the mortality of mice with respect to 2 aminoglycosides, gentamycin and dibekacin].
    Pariat C; Cambar J; Courtois P
    C R Seances Acad Sci III; 1983; 297(11):527-30. PubMed ID: 6421462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of habekacin in patients with renal insufficiency.
    Fillastre JP; Leroy A; Humbert G; Moulin B; Bernadet P; Josse S
    Antimicrob Agents Chemother; 1987 Apr; 31(4):575-7. PubMed ID: 3606062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of habekacin in patients with chronic renal insufficiency].
    Fillastre JP; Leroy A; Humbert G; Moulin B; Bernadet P; Josse S
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):739-41. PubMed ID: 3309806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Toxicological studies on dibekacin for intravenous injection use. I. Subacute toxicity in rats and rabbits (author's transl)].
    Koeda T; Odaki M; Sasaki H; Yokota M; Niizato T; Watanabe H; Kawaoto H; Hirano F; Kumagai K; Ishiwatari N; Suzuki H; Watanuki T
    Jpn J Antibiot; 1980 May; 33(5):580-98. PubMed ID: 7431659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.